Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Safety study of the SAG2 rabies virus mutant in several non-target species with a view to its future use for the immunization of foxes in Europe.

Vaccine - 1 Nov 1996

Masson E, Cliquet F, Aubert M, Barrat J, Aubert A, Artois M, Schumacher C L

Abstract excerpt

The safety of the SAG2 virus, a low virulence mutant of the SAD strain, was investigated in ten species of mammals and seven species of birds liable to consume vaccine baits. These species are the western hedgehog (Erinaceus europaeus), the meadow vole (Microtus arvalis), the bank vole (Clethrionomys glareolus), the water vole (Arvicola terrestris), the field mouse (Apodemus flavicollis or A. sylvaticus), the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Viral
Share to Birds
Share to Mice

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Share to Neutralization Tests

Share to Vaccines, Attenuated

Source

Identifiers

PMID: 9014291
DOI: 10.1016/s0264-410x(96)00114-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Safety study of the SAG2 rabies virus mutant in several non-target species with a view to its future use for the immunization of foxes in Europe.PMID 9014291Read ↗

Oral immunization of foxes with avirulent rabies virus mutants.Semantic proximity Read ↗

Vaccination against rabies: construction and characterization of SAG2, a double avirulent derivative of SADBern.Semantic proximity Read ↗

Immunogenicity and Safety of Recombinant Rabies Viruses Used for Oral Vaccination of Stray Dogs and WildlifeSemantic proximity Read ↗

In-Depth Characterization of Live Vaccines Used in Europe for Oral Rabies Vaccination of Wildlife.Semantic proximity Read ↗

Genetic characterisation of attenuated SAD rabies virus strains used for oral vaccination of wildlifeSemantic proximity Read ↗

Generation and characterization of a genetically modified live rabies vaccine strain with attenuating mutations in multiple viral proteins and evaluation of its potency in dogs.Semantic proximity Read ↗

Oral vaccination of wildlife using a vaccinia–rabies-glycoprotein recombinant virus vaccine (RABORAL V-RG®): a global reviewSemantic proximity Read ↗

Genetic stability (in vivo) of the attenuated oral rabies virus vaccine SAD B19.Semantic proximity Read ↗

Assessment of genetic changes and neurovirulence of shed Sabin and novel type 2 oral polio vaccine virusesSemantic proximity Read ↗

Avirulent mutants of rabies virus and their use as live vaccine.Semantic proximity Read ↗

Generation of a novel live rabies vaccine strain with a high level of safety by introducing attenuating mutations in the nucleoprotein and glycoprotein.Semantic proximity Read ↗

Immunogenicity and Safety of Serum-Free Rabies Vaccine (Vero Cell) for Human Use, Freeze-Dried with Different Immunization Schedules: A Randomized, Double-Blind, Active-Controlled Phase Ⅰ/Ⅲ Clinical TrialSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.